GlassScriptPhysician profile
Christopher H Renninger
NPI 1487917720
$6,653.87
in general payments reported to CMS, 2019-2025
12 companies · $65.99 in 2025
The $65.99 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $1,669 · 2021: $57.46 · 2022: $4,035 · 2023: $322 · 2024: $232 · 2025: $65.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,600.00 | 2022 | |
| Synthes Gmbh | $1,319.35 | 2020 | |
| Stryker Corporation | $739.59 | 2019-2024 | Aequalis Perform, T2 Alpha, Hoffmann |
| Smith+Nephew, INC. | $539.59 | 2019-2024 | Evos Mini, Evos, Memofix Super Elastic Nitinol Staple System |
| Biocomposites INC | $146.94 | 2019 | |
| Zimmer Biomet Holdings, INC. | $96.60 | 2020 | |
| Carbofix Orthopedics INC | $66.17 | 2022 | |
| Integra Lifesciences Corporation | $42.94 | 2019 | |
| Depuy Synthes Sales INC. | $34.12 | 2025 | Na |
| US Implant Solutions, LLC | $31.87 | 2025 | |
| Illuminoss Medical, INC. | $18.65 | 2022 | |
| Sanara Medtech INC. | $18.05 | 2023 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Renninger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.